Dermal Technology Laboratory Ltd

Across Barriers GmbH provides its customers services and consulting in the fields of in-vitro bioequivalence and pharmaceutical technological development.



Starting with analytical, physicochemical characterization, followed by testing of active com-pound properties on in vitro models for the feasibility, bioavailability, bioequivalence, and also customer oriented consultancy for drug formulation make it possible for Across Barriers to offer a complete service package for each question during the lifetime of the costumer’s product.



Across Barriers is certified in three GLP categories as well as for GMP. Since 2009 Across Barriers is FDA approved. Therefore, every project is performed under the common quality guidance but can also be conducted as a GLP or GMP study which is highly accepted at na-tional and international regulatory authorities.
A team of well-educated and experienced employees and a superbly equipped facility accom-plish the profile of Across Barriers.

APTYS is a CRDO (contract research and development organization) which develops innovative products based of its expertise in pharmaceutical technologies and peptide delivery.
APTYS offers ISO9001 aligned contract service, according to cGMP.
 Custom-made formulation development including in vivo/in vitro assessments.
 Semi solid dosage forms for topical and transdermal delivery.
 Injectable peptide depot formulations.
 Analytical development and validations.
 Quality control and ICH stability.

Edelweiss Connect is a Swiss company located in Basel, specialised in developing and implementing integrated scientific and technology solutions for industrial use and regulatory acceptance in areas of significant societal and market impact.

Our mission is to provide solutions addressing a range of important industrial safety problems supporting a safer intelligent design and risk assessment of products and their use (https://saferworldbydesign.com/). Towards this goal we work with our partners to provide a central place and platform where problems can be solved based on a combination of in silico and in vitro new approach methods.

We have extensive experience in scientific research and innovation integrating data, in silico and in vitro methods and related infrastructure into solutions, and have been involved in organising scientific, technical and knowledge management solution development projects since 2008.

Edelweiss Connect provides the expertise and experience to initiate, coordinate and manage large collaborative research projects, with partners from industry, government and academia. Our goal is to incubate high impact products, services and solutions at the forefront of innovation, with sustainability and responsibility.

EdelweissData™ is a unique platform for managing, harmonising and integrating data and is the foundation for our solution-based products and activities. In addition, we recently launched SaferSkin™, a cloud-based application for the integrated skin safety testing and assessment of ingredients and formulations.

We are also committed to human wellness and supporting the conservation of diverse ecosystems, wildlife, and biodiversity for future generations.

AGINKO Research is the premiere CRO for preclinical work in osteoarticular pathologies. We offer a wide range of contract research services to support Drug and Medical Device established companies as well as start-ups and academia. From industry standard protocols to customized research design, our animal models and assays, both on an in vivo or in vitro basis, provide key tools for compound discovery and product development.

Given our expertise, know-how, and network in the field of osteoarticular pathologies, AGINKO today also offers a full range of histology services for your preclinical and clinical trials as well as general consulting services (e.g., regulatory, strategy, financing) devoted to osteoarticular pathologies.


#Osteoarticular #CRO #Cartilage #Repair #Arthritis #Fracture #Osteoporosis #Preclinical #Pain #Disc #Spine #Infection

BioCentrum's mission is to create a platform for our clients and partners in order to help them translate innovative discoveries into preclinical candidates with improved chances to become marketed in the least amount of time possible. Our offer is a range of in vitro and in vivo assays that are created toward incorporating preclinical information into your pipeline.